Stockreport

Johnson & Johnson's Tremfya Shows Efficacy In Late-Stage Psoriatic Arthritis Study [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF arthritis (PsA) who are biologic naïve and have had an inadequate response to standard therapies The study achieved its primary endpoint (ACR20a) of reducing signs and [Read more]